Skip to content

Clinical trials

Phase 3 Venous Thrombosis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Venous Thrombosis Phase: Phase 3 Country / region: Germany Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20077
20085
20091
20101
20131
20141
20171
20181
20201
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated6
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb5
Bayer3
GlaxoSmithKline3
Anthos Therapeutics, Inc.2
Daiichi Sankyo2
Sanofi2
Healthpoint1
Novartis1
Population Health Research Institute1
Prof. Stavros Konstantinides, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Venous Thrombosis24
Pulmonary Embolism12
Venous Thromboembolism11
Thromboembolism3
Thrombosis3
COVID-191
Carcinoma, Non-Small-Cell Lung1
Embolism and Thrombosis1
Gastrointestinal Neoplasms1
Hypertension1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.